Allied Healthcare Products
AHPI
AHPI was delisted on the 2nd of February, 2023.
12 hedge funds and large institutions have $414K invested in Allied Healthcare Products in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
9% more funds holding
Funds holding: 11 → 12 (+1)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
65% less capital invested
Capital invested by funds: $1.19M → $414K (-$771K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$35.3K |
| 2 |
HF
HRT Financial
New York
|
+$34.7K |
| 3 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$22.7K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.42K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$454 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$285K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$33K |
| 3 |
Morgan Stanley
New York
|
-$17.3K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$17.1K |
| 5 |
Renaissance Technologies
New York
|
-$4.76K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $112K | -$285K | -125,474 | -65% |
|
|
2
Renaissance Technologies
New York
| $99K | -$4.76K | -2,100 | -3% |
|
|
3
Dimensional Fund Advisors
Austin,
Texas
| $60K | -$17.1K | -7,553 | -17% |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $36K | +$1.42K | +624 | +3% |
|
|
SSA
5
Schonfeld Strategic Advisors
New York
| $29K | +$454 | +200 | +1% |
|
|
6
Millennium Management
New York
| $25K | +$35.3K | +15,578 | New |
|
|
HF
7
HRT Financial
New York
| $24K | +$34.7K | +15,293 | New |
|
|
TDC
8
Thompson Davis & Co
Richmond,
Virginia
| $16K | +$22.7K | +10,000 | New |
|
|
9
Morgan Stanley
New York
| $13K | -$17.3K | -7,628 | -49% |
|
|
TSS
10
Two Sigma Securities
New York
| – | -$33K | -10,344 | Closed |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | -$4K | -1,228 | Closed |
|
12
UBS Group
Zurich,
Switzerland
| – | -$4K | -1,220 | Closed |
|
13
Wells Fargo
San Francisco,
California
| – | +$5 | +2 | +10% |
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$227 | +100 | New |
|
15
Osaic Holdings
Scottsdale,
Arizona
| – | +$268 | +118 | +190% |
|
AHPI Hedge Fund Activity: Q2 2022 in Review
12 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q2 2022, worth a combined $414K — down 65% from $1.19M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new AHPI positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $35.3K. The largest seller was Vanguard Group, cutting an estimated $285K.
- 12 institutional investors held Allied Healthcare Products (AHPI) as of Q2 2022, up from 11 in Q1 2022.
- Funds reported $414K of Allied Healthcare Products stock for Q2 2022, down 65% quarter-over-quarter.
- 4 funds opened new Allied Healthcare Products positions in Q2 2022 and 3 closed out, a net change of +1 holder.
- The largest Allied Healthcare Products buyer in Q2 2022 was Millennium Management, an estimated $35.3K added.
- The largest Allied Healthcare Products seller in Q2 2022 was Vanguard Group, an estimated $285K sold.
Based on aggregated 13F filings for Q2 2022.